David B. Patience
Chief Financial OfficerMr. David B. Patience is Chief Financial Officer of TriSalus Life Sciences, Inc. from July 1, 2025. Mr. Patience joined TriSalus from Accelerate Diagnostics, where he served as Chief Financial Officer at Accelerate Diagnostics, Inc. since April 01, 2023 until June 30, 2025. He has extensive experience in leading strategic product portfolio planning, in-depth market analysis of organic and in-organic portfolio opportunities and technical and commercial feasibility analysis of partnerships, mergers and acquisitions. He previously served as Senior Director - Head of Business Development and Strategic Finance at Accelerate Diagnostics, Inc. from January 2021 to March 2023. Mr. Patience held the position of Director, Head of Finance, Planning and Analysis and Corporate Development, September 2017-January 2021. Throughout his time with Accelerate Diagnostics, Inc. Mr. Patience has led strategic product portfolio planning which includes in-depth market analysis of organic and in-organic portfolio opportunities and technical and commercial feasibility to deliver financial analysis of Partnerships, mergers and acquisitions and organic programs. Most recently, Mr. Patience has led operationalizing the company's recent commercial arrangement with Becton, Dickinson and Company. Prior to joining Accelerate Diagnostics, Inc. Mr. Patience's prior positions include with Morgan Stanley's Investment Banking Division, equity research at Continental Advisors and various financial research roles at Nuveen Investments. Mr. Patience holds a Bachelor of Science in Business Administration from the University of Colorado Leeds School of business and a M.B.A. from University of Chicago's Booth School of business.
Positions
- Company NameTriSalus Life Sciences, Inc.Stock CodeTLSIPositionChief Financial OfficerRelated SecuritiesColleagues
- MTMary T. SzelaCEO, President & Director
- MLMats L. WahlstromIndependent Chairman
- RBRichard B. MarshakChief Commercial Officer
- AMAndrea MarassoVice President of Marketing
- JLJennifer L. StevensChief Regulatory, Quality and Therapeutics Officer
- KRKerry R. HicksIndependent Director
- DJDavid J. MatlinIndependent Director
- WJWilliam J. ValleIndependent Director
